Oncotarget: MEK is a promising target in the basal subtype of bladder cancer
Bioengineer.org,
“The @Oncotarget authors demonstrate that MEK inhibitors are a promising targeted therapy for the basal subtype of bladder…
“The @Oncotarget authors demonstrate that MEK inhibitors are a promising targeted therapy for the basal subtype of bladder…
“The @Oncotarget authors demonstrate that MEK inhibitors are a promising targeted therapy for the basal subtype of bladder…
Oncotarget recently published in "MEK is a promising target in the basal subtype of bladder cancer" by Merrill, et al.
Newswise — Researchers at the University of Michigan Rogel Cancer Center have identified a promising targeted therapy against…
Post Views: 1 Researchers at the University of Michigan Rogel Cancer Center have identified a promising targeted therapy…